ARS Pharmaceuticals, Inc. — Director's Dealing 2024

Jun 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARS Pharmaceuticals, Inc. (SPRY)
CIK: 0001671858
Period of Report: 2024-06-13

Reporting Person: Shah Pratik (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-13	Common Stock	G	200000	—	Disposed	1132900	Indirect
2024-06-13	Common Stock	G	1132900	—	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4824554	Indirect

Footnotes

F1: This transaction involved the gift of shares by the Reporting Person's spouse to the Reporting Person's father-in-law.

F2: This transaction involved the gift by the Reporting Person's spouse to an irrevocable trust of which the Reporting Person's spouse is settlor.

F3: The Reporting Person is the trustee of The Pratik Shah Living Trust dated June 15, 2011.